Skip to content

Clinical trials

Non-alcoholic Fatty Liver Disease trials in Argentina

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Non-alcoholic Fatty Liver Disease Country / region: Argentina Clear all

26 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20162
20172
20181
20191
20205
20215
20221
20233
20243
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated10
Completed6
Active, not recruiting4
Recruiting4
Not yet recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals5
89bio, Inc.2
Akero Therapeutics, Inc2
AstraZeneca2
GlaxoSmithKline2
Merck Sharp & Dohme LLC2
Bristol-Myers Squibb1
Eli Lilly and Company1
Enanta Pharmaceuticals, Inc1
Galectin Therapeutics Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Non-alcoholic Fatty Liver Disease26
Fatty Liver6
Fibrosis6
Liver Diseases5
Liver Cirrhosis3
Digestive System Diseases2
Metabolic Diseases2
Acquired Immunodeficiency Syndrome1
Diabetes Mellitus, Type 21
Esophageal and Gastric Varices1

Trials

Showing 1 to 25 of 26. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.